Buspirone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Conditions: Generalized Anxiety Disorder Interventions: Drug: Buagafuran capsules, 15mg/ capsule; Drug: Buspirone tablets, 5mg/ tablet; Drug: Buagafuran capsules mimic, 0mg/ capsule; Drug: Buspirone tablets mimic, 0mg/ tablet Sponsors: Beijing Union Pharmaceutical Factory Ltd; R&G Pharma Studies Co.,Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

Buspirone for Weak or Absent Esophageal Peristalsis
Condition:   Dysphagia, Esophageal Interventions:   Drug: Buspirone Hydrochloride 10 MG;   Drug: Placebo Sponsor:   Universitaire Ziekenhuizen KU Leuven Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2022 Category: Research Source Type: clinical trials

Evaluating Buspirone to Treat Opioid Withdrawal
Conditions:   Opioid Use Disorder;   Opioid Withdrawal;   Opioid Craving;   Anxiety Interventions:   Drug: Buspirone;   Drug: Lofexidine;   Drug: Placebo Sponsor:   Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2022 Category: Research Source Type: clinical trials